Trial intelligence / Profile preview

Vitamin C for the Prevention of Catheter-associated Urinary Tract Infections in Women Who Undergo Elective Gynecological Surgeries

NCT04261036Phase 1Withdrawn

Sponsor
American University of Beirut Medical Center
Start
Jul 2019
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in catheter-associated urinary tract infection (CAUTI) comparing Women on a vitamin C regimen with Women on a placebo regimen (2 arms). Primary endpoint: Proportion of participants who experienced clinically diagnosed and treated UTI at 14 days. Planned start Jul 2019; status: withdrawn.

02

Drugs

ascorbic acid
03

Conditions

catheter-associated urinary tract infection (CAUTI)

Beyond the preview

Go deeper on NCT04261036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04261036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call